Recursion Pharmaceuticals
RXRX
RXRX
75 hedge funds and large institutions have $1.71B invested in Recursion Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holding in Top 10
6
Calls
$705K
Puts
–
Top Buyers
| 1 | +$548M | |
| 2 | +$114M | |
| 3 | +$79.4M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$70.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$65.5M |
Top Sellers
No sellers this quarter